Clinicians' Attitudes toward General Screening of the Ashkenazi-Jewish Population for Prevalent Founder BRCA1/2 and LRRK2 Mutations

Publisher： Karger

E-ISSN： 1662-8063|16|4|174-183

ISSN： 1662-4246

Source： Public Health Genomics, Vol.16, Iss.4, 2013-06, pp. : 174-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population

By Bronstein Michal   Pisanté Anne   Yakir Benjamin   Darvasi Ariel  

Human Genetics, Vol. 124, Iss. 1, 2008-08 ,pp. : 101-104

Springer Publishing Company

Access to resources Recommend Favorite

Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population

By  

Molecular Genetics & Genomic Medicine, Vol. 3, Iss. 2, 2015-03 ,pp. : 137-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Tyr978X BRCA1 Mutation in Non-Ashkenazi Jews: Occurrence in High-Risk Families, General Population and Unselected Ovarian Cancer Patients

By  

Public Health Genomics, Vol. 4, Iss. 1, 2001-07 ,pp. : 50-55

Karger

Access to resources Recommend Favorite

Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population

By Shaag Avraham  

Human Molecular Genetics, Vol. 14, Iss. 4, 2005-02 ,pp. : 555-563

Oxford University Press

Access to resources Recommend Favorite

Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next‐generation sequencing

By  

Molecular Genetics & Genomic Medicine, Vol. 3, Iss. 2, 2015-03 ,pp. : 121-129

John Wiley & Sons Inc

Access to resources Recommend Favorite